Drug Shortage Report for SANDOZ BRIMONIDINE

Last updated on 2021-01-12 History
Report ID 130191
Drug Identification Number 02305429
Brand name SANDOZ BRIMONIDINE
Common or Proper name BRIMONIDINE SDZ
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ml
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-15
Estimated end date 2021-01-08
Actual end date 2021-01-08
Shortage status Resolved
Updated date 2021-01-12
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-01-12 French Compare
v4 2021-01-12 English Compare
v3 2020-12-16 English Compare
v2 2020-12-15 French Compare
v1 2020-12-15 English Compare